Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. (Q45921292)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Diego Centonze

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Valeria Studer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

10

G Cutter

0 references

author name string

C Motta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

V De Chiara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

F Barbieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

F Monteleone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A Fornasiero

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

G Coarelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

G Bernardi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

O Stüve

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Salvetti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

87-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

PML: underdiagnosed in MS patients on natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Natalizumab drug holiday in multiple sclerosis: poorly tolerated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Anti-JC virus antibodies: implications for PML risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Treatment of multiple sclerosis: role of natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Course of relapsing-remitting multiple sclerosis before, during and after natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03794.X

10.1111/J.1468-1331.2012.03794.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22741530%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference